Safety and Immunogenicity of GSK's Tdap Vaccine (Boostrix) in Adults Aged 19 to 64 Years

Clinical trial NCT00346073 · COMPLETED

Trial details

NCT number: NCT00346073
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acellular Pertussis Diphtheria Tetanus

Start date: 2006-07-13
Primary completion: 2007-03-01
Enrollment: 2337

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.